GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of switched from 2.5mg to 10mg and the early fullness got better, not worse — 37 comments in the full submission. View in context.
13k
c/retatrutide·submitted 1 year ago by u/yannick_barros

switched from 2.5mg to 10mg and the early fullness got better, not worse

Trial Databranch of 8 comments

Trying to settle this properly because the thread from last year went in circles. The claim: glucagon matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 8 months without either producing anything. What would actually settle it is 27 people measuring the same…

Read the full submission and all 37 comments →

This branch

8 comments, started 1 year ago
u/signe_villalobos386 points·1 year ago
this is the third time this week and i love it every time
replysharereportpermalink
u/divya_bakken232 points·1 year ago

nobody should be giving this to anyone without extensive monitoring

replysharereportpermalink
u/signe_villalobos124 points·1 year ago

nobody should be giving this to anyone without extensive monitoring

Disagree on that part. 99.0% and 98.9% on the same vial is normal.

replysharereportpermalink
u/andres_sorensen64 points·1 year ago

phase 2 numbers are not maintenance numbers, cite the trial

replysharereportpermalink
u/reta_and_regret49 points·1 year ago

phase 2 numbers are not maintenance numbers, cite the trial

Adding to this: triple agonist is doing more work than the comment implies.

replysharereportpermalink
u/marta_vanhecke0 points·1 year ago

phase 2 numbers are not maintenance numbers, cite the trial

replysharereportpermalink
u/tired_ledger_notes1 point·1 year ago

triple agonism is phase 2, do not generalise

replysharereportpermalink
u/arne_amankwah336 points·1 year ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →